Primary Site >> Colorectal Cancer

Gene >> IFNA2

Journal: Int J Cell Cloning. 1985 Jul;3(4):188-98.
Title: In vitro phase II trial of recombinant interferon alpha-2 in gastrointestinal cancer.
Author: Scheithauer, W|Temsch, E M|Schieder, K|Funovics, H|Schiessel, R|Grabner, G
PMID: 4020167
Journal: Acta Oncol. 1991;30(1):7-10.
Title: Protracted intravenous infusion of 5-fluorouracil in combination treatments. A review.
Author: Hansen, R M
PMID: 2009187
Journal: Surg Today. 1992;22(5):481-3.
Title: Interferon alpha-2a shows antitumor activity in combination with 5-fluorouracil against human colon carcinoma xenografts: a study in reference to thymidylate synthetase activity inhibition.
Author: Kubota, T|Inada, T|Ogata, Y
PMID: 1421872
Journal: Ann Oncol. 1992 Jun;3(6):489-91.
Title: Double biochemical modulation of 5-fluorouracil by leucovorin and cyclic low dose interferon alpha 2b in advanced colorectal cancer patients.
Author: Cascinu, S|Fedeli, A|Fedeli, S L|Catalano, G
PMID: 1498068
Journal: Cancer. 1992 Sep 1;70(5 Suppl):1414-24.
Title: Chemotherapy for metastatic colorectal cancer.
Author: Mayer, R J
PMID: 1511393
Journal: Eur J Cancer. 1992;28A(4-5):850-2.
Title: Phase II study of 5-fluorouracil plus leucovorin and interferon alpha 2b in advanced colorectal cancer.
Author: Sobrero, A|Nobile, M T|Guglielmi, A|Mori, A|Aschele, C|Bolli, E|Tixi, L|Gallo, L|Parodi, G C|Bruzzi, P
PMID: 1524906
Journal: Semin Oncol. 1992 Apr;19(2 Suppl 4):57-62.
Title: A phase II trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma.
Author: Kreuser, E D|Hilgenfeld, R U|Matthias, M|Hoksch, B|Boewer, C|Oldenkott, B|Lenk, H|Wiener, N|Boese-Landgraf, J|Schalhorn, A
PMID: 1553576
Journal: Semin Oncol. 1992 Apr;19(2 Suppl 3):197-203.
Title: A phase I trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma.
Author: Kreuser, E D|Hilgenfeld, R U|Matthias, M|Hoksch, B|Boewer, C|Oldenkott, B|Knauf, W U|Boese-Landgraf, J|Schalhorn, A|Zeitz, M
PMID: 1557647
Journal: Cancer. 1992 Feb 15;69(4):889-92.
Title: A phase I trial of 5-fluorouracil, folinic acid, and alpha-2a-interferon in patients with metastatic colorectal carcinoma.
Author: Bukowski, R M|Inoshita, G|Yalavarthi, P|Murthy, S|Gibson, V|Budd, G T|Sergi, J S|Bauer, L|Prestifilippo, J
PMID: 1735080
Journal: Cancer Res. 1993 Sep 15;53(18):4243-50.
Title: Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells.
Author: Houghton, J A|Morton, C L|Adkins, D A|Rahman, A
PMID: 8364921
Journal: Eur J Cancer. 1993;29A(12):1715-20.
Title: Phase I-II study of the addition of alpha-2a interferon to 5-fluorouracil/leucovorin. Pharmacokinetic interaction of alpha-2a interferon and leucovorin.
Author: Sinnige, H A|Buter, J|de Vries, E G|Uges, D R|Roenhorst, H W|Verschueren, R C|Sleijfer, D T|Willemse, P H|Mulder, N H
PMID: 8398300
Journal: Oncol Rep. 1994 Jul;1(4):755-7.
Title: Double alternate modulation of high-dose 5-Fluorouracil by interferon-alpha-2b and phosphonacetyl-L-aspartic Acid in patients with advanced colorectal-cancer.
Author: Punt, C|Burghouts, J|Kateman, I|Croles, J|Kamm, Y|Wagener, D
PMID: 21607436
Journal: J Cancer Res Clin Oncol. 1994;120(5):314-8.
Title: Double modulation of 5-fluorouracil by high-dose leucovorin and interferon alpha 2b in advanced colorectal cancer: a phase I and a phase II study of weekly administration.
Author: Steger, G G|Mader, R M|Djavanmard, M P|Gnant, M F|Locker, G|Marosi, C|Rainer, H|Jakesz, R
PMID: 8126062
Journal: Br J Cancer. 1994 Oct;70(4):724-8.
Title: Lack of effect of interferon alpha 2a upon fluorouracil pharmacokinetics.
Author: Seymour, M T|Patel, N|Johnston, A|Joel, S P|Slevin, M L
PMID: 7917928
Journal: Eur J Cancer. 1995;31A(3):315-20.
Title: Different dose regimens of 5-fluorouracil and interferon-alpha in patients with metastatic colorectal carcinoma.
Author: Ragnhammar, P|Blomgren, H|Edler, D|Lundell, G|Magnusson, I|Sonnenfeld, T
PMID: 7786594
Journal: Med Oncol. 1995 Mar;12(1):47-53.
Title: Pharmacokinetic interaction of 5-fluorouracil and interferon alpha-2b with or without folinic acid.
Author: b1p6uller, J|Czejka, M
PMID: 8542247
Journal: J Interferon Cytokine Res. 1995 Dec;15(12):1089-93.
Title: Dual modulation by l-leucovorin and recombinant human interferon alpha 2a of 5-fluorouracil antitumor activity against the human colon carcinoma xenograft Co-4.
Author: Kase, S|Kubota, T|Watanabe, M|Furukawa, T|Tanino, H|Kuo, T H|Saikawa, Y|Teramoto, T|Kitajima, M
PMID: 8746791
Journal: Cancer Chemother Pharmacol. 1996;38(4):385-6.
Title: Multimodal biochemical modulation of 5-fluorouracil by leucovorin, methotrexate, and interferon alpha in patients with advanced colorectal cancer.
Author: Cascinu, S|Alessandroni, P|Rossi, D|Del Ferro, E|Fedeli, A|Casadei, V|Catalano, G
PMID: 8674163
Journal: J Clin Oncol. 1996 Aug;14(8):2280-8.
Title: Randomized trial assessing the addition of interferon alpha-2a to fluorouracil and leucovorin in advanced colorectal cancer. Colorectal Cancer Working Party of the United Kingdom Medical Research Council.
Author: Seymour, M T|Slevin, M L|Kerr, D J|Cunningham, D|James, R D|Ledermann, J A|Perren, T J|McAdam, W A|Harper, P G|Neoptolemos, J P|Nicholson, M|Duffy, A M|Stephens, R J|Stenning, S P|Taylor, I
PMID: 8708718
Journal: Ann Acad Med Singapore. 1996 Mar;25(2):210-4.
Title: A report of infusional 5-fluorouracil and subcutaneous alpha-2A-interferon in the treatment of advanced colorectal carcinoma.
Author: Koo, W H|Ang, P T
PMID: 8799007
Journal: Anticancer Drugs. 1996 Jul;7(5):520-4.
Title: A phase I trial of 5-fluorouracil, leucovorin and interferon-alpha 2b administered by 24 h infusion in metastatic colorectal carcinoma.
Author: Cascinu, S|Del Ferro, E|Ligi, M|Catalano, G
PMID: 8862717
Journal: Cancer Immunol Immunother. 1996 Oct;43(2):94-102.
Title: The prognostic significance of immune changes in patients with renal cancer, melanoma and colorectal cancer, treated with interferon alpha 2b.
Author: Tsavaris, N|Baxevanis, C|Kosmidis, P|Papamichael, M
PMID: 8954143
Journal: Anticancer Res. 1997 Jan-Feb;17(1B):725-8.
Title: Interferons alpha-2a and beta increase the antitumor activity, detected by MTT assay, of 5-fluorouracil against experimental and clinical human gastrointestinal carcinomas.
Author: Kubota, T|Kase, S|Otani, Y|Watanabe, M|Teramoto, T|Kitajima, M
PMID: 9066609
Journal: Clin Cancer Res. 1997 Jul;3(7):1125-34.
Title: A pilot study of gamma-1b-interferon in combination with fluorouracil, leucovorin, and alpha-2a-interferon.
Author: Grem, J L|McAtee, N|Murphy, R F|Balis, F M|Cullen, E|Chen, A P|Hamilton, J M|Steinberg, S M|Quinn, M|Sorensen, J M|Arbuck, S G|Lawrence, D|Pang, J|Allegra, C J
PMID: 9815792
Journal: Anticancer Drugs. 1999 Jul;10(6):519-24.
Title: Phase II trial of 5-fluorouracil, folinic acid and recombinant alpha-2a-interferon in patients with advanced colorectal cancer.
Author: Ravandi, F|Rytting, M E|Osmon, C|Braud, E L|Roach, R W|Edwards, K|Winn, R|Abbruzzese, J L|Pazdur, R
PMID: 10885898
Journal: Dermatology. 2000;200(4):331-3.
Title: Muir-Torre syndrome - treatment with isotretinoin and interferon alpha-2a can prevent tumour development.
Author: Graefe, T|Wollina, U|Schulz, H|Burgdorf, W
PMID: 10894967
Journal: Kongressbd Dtsch Ges Chir Kongr. 2002;119:142-5.
Title: [Interferon-alpha in adjuvant treatment of colorectal carcinoma].
Author: Staib, L|Link, K H|Henne-Bruns, D
PMID: 12704877